Virtual Molecular Rounds

March to December, 2026

VMR’S HOME   |   FACULTY   |   SPONSORS   |   RECORDED SESSIONS

Next Round: Monday, June 22, 2026

REGISTER FOR THE NEXT POET VMR

WELCOME TO POET MOLECULAR ROUNDS

POET National Virtual Molecular Rounds is a one hour monthly educational program which takes place at 12PM MT / 11 AM PT / 2 PM ET/ 3 PM ATL.

POET is an academic program based out of the University of Calgary focused on Precision Oncology biomarker discovery, registries and access to novel diagnostics and therapeutics. POET strives to have accessible education across Canada for health care clinicians about molecular diagnostics and advancements in precision oncology biomarker driven practice.

By the end of the webinar series, each audience member will have the opportunity to:

  1. Learn the latest developments in molecular oncology and precision medicine through world-renowned speakers.
  2. Discuss and understand approaches to the challenging clinical interpretation of comprehensive genomic profile results shared among experts.
  3. Discuss areas of controversy and the challenges of molecular and polyomic diagnostics in relation to biomarker driven precision oncology therapeutics.

We look forward to this very informative virtual webinar series.

Best regards,

Dr. Pinaki Bose
Scientific Lead, POET Molecular Rounds

Dr. Steven Yip
Medical Lead, POET Molecular Rounds

Dr. Megan Mahoney,
Principal POET Ambassador,
Virtual Molecular Rounds 

NEXT VMR:

Monday, June 22, 2026
(Times listed in Mountain Time)

Please note this session begins at 12PM MT / 11 AM PT / 2 PM ET/ 3 PM ATL.
12:00 PM – 12:05 PM Welcome Remarks Dr. Steven Yip, POET VMR Co-Chair
12:05 PM – 12:50 PM Dynamic CAR T Cell Development for MiT/TFE-Family Fusion-Driven Solid Tumors

Learning Objectives:

  1. Understand the challenges associated with CAR T cell therapy of solid tumours
  2. Learn about GCAR1 development for rare cancers expressing GPNMB, a transcriptional target of MiT/TFE gene fusions
  3. Be introduced to the concept of dynamic CAR T cell development in the academic setting
 Douglas J. Mahoney, PhD
Associate Professor of Microbiology, Immunology, and Infectious Disease
Associate Director, Basic and Translational Research, Charbonneau Cancer Institute
Director, Riddell Centre for Cancer Immunotherapy
Calgary, AB
12:50 PM – 12:55 PM Panel Discussion Dr. Douglas J. Mahoney & POET VMR Chairs: Dr. Steven Yip, Dr. Pinaki Bose, Dr. Meghan Mahoney
12:55 PM – 1:00 PM Audience Questions & Answers
1:00 PM Closing Remarks Dr. Steven Yip, POET VMR Co-Chair
REGISTER FOR THE NEXT POET VMR

PREVIOUS VMR:

Tuesday, May 26, 2026
(Times listed in Mountain Time)

Please note this session begins at 12PM MT / 11 AM PT / 2 PM ET/ 3 PM ATL.
12:00 PM – 12:05 PM Welcome Remarks Dr. Steven Yip, POET VMR Co-Chair
12:05 PM – 12:50 PM Type 2 Innate Lymphoid Cells in Cancer: Mechanisms and Therapeutic Implications

Learning Objectives:

  1. Understand the complexity of the tumor microenvironment
  2. Appreciate the emerging impact of rare immune cells in tumor development, progression and treatment responses
  3. Recognize the importance of increasing our understanding of the tumor immune contexture to identify novel therapeutic targets.
 Dr. Nicolas Jacquelot, PhD,
Assistant Professor, University of Calgary
Principal Investigator, Immunophenotyping Program, Riddell Centre for Cancer Immunotherapy
Calgary, AB
12:50 PM – 12:55 PM Panel Discussion Dr. Nicolas Jacquelot & POET VMR Chairs: Dr. Steven Yip, Dr. Pinaki Bose, Dr. Meghan Mahoney
12:55 PM – 1:00 PM Audience Questions & Answers
1:00 PM Closing Remarks Dr. Steven Yip, POET VMR Co-Chair